Historical record - last NADAC publication: 5/17/2017
Product Information
GLEEVEC 100 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $90.8197 per EA under NDC 00078040134. Its NADAC has been published 234 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the imatinib mesylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078040134
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
5/17/2017
Active Ingredients
IMATINIB MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA021588On Market Since
5/15/2001
Pharmacological Classes
Price Statistics
The NADAC for GLEEVEC 100 MG TABLET has been published 234 times since Nov 28, 2013, and over the history we have for it it has risen 46.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $90.8197 per EA |
|---|---|
| All-time high | $92.6029 (Apr 13, 2016) |
| All-time low | $61.9629 (Nov 28, 2013) |
| Median price | $90.5027 |
| Average price | $84.5953 |
| Largest weekly change | +9.9% (Jan 15, 2014) |
| Weeks tracked | 234 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLEEVEC 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLEEVEC 100 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $90.8197 per EA (NDC 00078040134), effective May 16, 2018.
How has the price of GLEEVEC 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLEEVEC 100 MG TABLET has risen 46.6%. It has been tracked across 234 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLEEVEC 100 MG TABLET?
Since Nov 28, 2013, the NADAC for GLEEVEC 100 MG TABLET has ranged from a low of $61.9629 (Nov 28, 2013) to a high of $92.6029 (Apr 13, 2016), with a median of $90.5027 per EA.
Are there cheaper alternatives to GLEEVEC 100 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IMATINIB MESYLATE 100 MG TAB, is $0.4912 per EA — about 99% below GLEEVEC 100 MG TABLET.
Who manufactures GLEEVEC 100 MG TABLET?
GLEEVEC 100 MG TABLET (NDC 00078040134) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification